Nitrazepam
- Generic Name
- Nitrazepam
- Brand Names
- Mogadon
- Drug Type
- Small Molecule
- Chemical Formula
- C15H11N3O3
- CAS Number
- 146-22-5
- Unique Ingredient Identifier
- 9CLV70W7HS
- Background
A benzodiazepine derivative used as an anticonvulsant and hypnotic.
- Indication
Used to treat short-term sleeping problems (insomnia), such as difficulty falling asleep, frequent awakenings during the night, and early-morning awakening.
- Associated Conditions
- Insomnia, Myoclonic seizures
Pharmacovigilance in Gerontopsychiatric Patients
Phase 3
Terminated
- Conditions
- DementiaDepressionSchizophreniaPsychosomatic DisordersAnxiety Disorders
- Interventions
- First Posted Date
- 2015-03-02
- Last Posted Date
- 2018-02-28
- Lead Sponsor
- Hannover Medical School
- Target Recruit Count
- 407
- Registration Number
- NCT02374567
- Locations
- 🇩🇪
Bezirkskrankenhaus Augsburg, Augsburg, Germany
🇩🇪Krankenhaus Hedwigshöhe, Berlin, Germany
🇩🇪Hannover Medical School, Hannover, Germany
A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients
Phase 3
Completed
- Conditions
- Sleep Initiation and Maintenance Disorders
- Interventions
- First Posted Date
- 2006-09-11
- Last Posted Date
- 2014-08-20
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 450
- Registration Number
- NCT00374777
Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment
Phase 2
Completed
- Conditions
- Spasms, InfantileEpilepsy
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 30
- Registration Number
- NCT00004758
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath